https://www.selleckchem.com/products/mycro-3.html
53, 95% confidence interval 1.34 to 1.75). Support for bringing a COC OTC increased marginally for those who received OTC and POP information, while support among those who received only OTC information increased by 12 percentage points (to 50%). Among clinicians opposed to moving a POP OTC after receiving information, top concerns included safety (26%), effectiveness (19%), potential for incorrect use (19%), and loss of preventive screenings (15%). Conclusion Evidence-based information, particularly around POPs, has the potential to ch
Like
Comment
Share
